SICHUAN DOWELL SCIENCE AND TECHNOLOGY INC. Financials Sichuan Dowell Science and Technology Inc.
Equities
300535
CNE100002CQ3
Commodity Chemicals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.55 CNY | +4.88% |
|
-1.17% | -22.62% |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 1,344 | 1,422 | 1,461 | 1,635 | 1,344 | 1,836 |
| Enterprise Value (EV) 1 | 1,230 | 1,344 | 1,452 | 1,735 | 1,514 | 2,040 |
| P/E ratio | 31.8 x | 35.7 x | 25 x | 24.5 x | -730 x | 64.4 x |
| Yield | 0.82% | 0.58% | 0.64% | 0.64% | - | 0.4% |
| Capitalization / Revenue | 3.77 x | 3.59 x | 3.11 x | 2.6 x | 2.63 x | 2.53 x |
| EV / Revenue | 3.45 x | 3.39 x | 3.09 x | 2.75 x | 2.97 x | 2.81 x |
| EV / EBITDA | 20.8 x | 19.8 x | 16.5 x | 16.3 x | 50.4 x | 23.4 x |
| EV / FCF | -24 x | 87.5 x | -17.8 x | -20.1 x | -356 x | -92.6 x |
| FCF Yield | -4.17% | 1.14% | -5.61% | -4.97% | -0.28% | -1.08% |
| Price to Book | 1.81 x | 1.89 x | 1.78 x | 1.82 x | 1.49 x | 1.95 x |
| Nbr of stocks (in thousands) | 104,396 | 103,938 | 104,016 | 104,216 | 104,583 | 104,843 |
| Reference price 2 | 12.87 | 13.68 | 14.05 | 15.69 | 12.85 | 17.51 |
| Announcement Date | 11/04/19 | 23/04/20 | 25/04/21 | 21/04/22 | 27/04/23 | 22/04/24 |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 356.1 | 396.3 | 469.6 | 629.8 | 510.4 | 724.6 |
| EBITDA 1 | 59.24 | 67.75 | 87.98 | 106.7 | 30.05 | 87.26 |
| EBIT 1 | 41.51 | 42.8 | 53.23 | 72.5 | -4.84 | 47.01 |
| Operating Margin | 11.66% | 10.8% | 11.34% | 11.51% | -0.95% | 6.49% |
| Earnings before Tax (EBT) 1 | 48.39 | 43.14 | 57.29 | 71.67 | -12.99 | 10.87 |
| Net income 1 | 41.41 | 39.37 | 57.03 | 65.84 | -1.828 | 28.43 |
| Net margin | 11.63% | 9.93% | 12.14% | 10.45% | -0.36% | 3.92% |
| EPS 2 | 0.4043 | 0.3834 | 0.5627 | 0.6416 | -0.0176 | 0.2719 |
| Free Cash Flow 1 | -51.33 | 15.37 | -81.52 | -86.23 | -4.254 | -22.03 |
| FCF margin | -14.41% | 3.88% | -17.36% | -13.69% | -0.83% | -3.04% |
| FCF Conversion (EBITDA) | - | 22.68% | - | - | - | - |
| FCF Conversion (Net income) | - | 39.03% | - | - | - | - |
| Dividend per Share 2 | 0.1050 | 0.0800 | 0.0900 | 0.1000 | - | 0.0700 |
| Announcement Date | 11/04/19 | 23/04/20 | 25/04/21 | 21/04/22 | 27/04/23 | 22/04/24 |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | 99.9 | 170 | 204 |
| Net Cash position 1 | 114 | 77.4 | 9.33 | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | 0.936 x | 5.657 x | 2.337 x |
| Free Cash Flow 1 | -51.3 | 15.4 | -81.5 | -86.2 | -4.25 | -22 |
| ROE (net income / shareholders' equity) | 6.02% | 5.38% | 6.79% | 7.16% | -1.83% | 0.37% |
| ROA (Net income/ Total Assets) | 3.45% | 3.22% | 3.39% | 3.84% | -0.24% | 2.17% |
| Assets 1 | 1,201 | 1,224 | 1,684 | 1,714 | 776.5 | 1,310 |
| Book Value Per Share 2 | 7.100 | 7.250 | 7.910 | 8.620 | 8.600 | 8.960 |
| Cash Flow per Share 2 | 0.4200 | 0.3300 | 0.5700 | 0.4400 | 0.5700 | 0.6600 |
| Capex 1 | 75 | 57.1 | 27.6 | 107 | 59.8 | 98.3 |
| Capex / Sales | 21.05% | 14.4% | 5.88% | 17.04% | 11.71% | 13.56% |
| Announcement Date | 11/04/19 | 23/04/20 | 25/04/21 | 21/04/22 | 27/04/23 | 22/04/24 |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -22.62% | 187M | |
| +6.11% | 105B | |
| -4.67% | 63.83B | |
| +73.81% | 45.28B | |
| +15.46% | 38.93B | |
| +5.46% | 33.06B | |
| +11.59% | 20.21B | |
| +13.74% | 16.94B | |
| +20.05% | 16.08B | |
| +5.02% | 14.49B |
- Stock Market
- Equities
- 300535 Stock
- Financials Sichuan Dowell Science and Technology Inc.
